Trial | NCT00310505  Report issue

Title

Amphotericin B Treatment in Visceral Leishmaniasis
Randomised Double Blind Dose Ranging Study of Amphotericin B in Visceral Leishmaniasis

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    1500
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.
Study Started
Jan 31
2003
Last Update
Sep 12
2008
Estimate

Drug Amphotericin B deoxycholate given as daily administration

Criteria 

Inclusion Criteria:

Parasitologically proved kala-azar

Exclusion Criteria:

HIV positive serology
No Results Posted